The combination of non-rodent genetics and molecular biology may significantly contribute to the understanding of the role of LRRK2 in Parkinson’s disease and pave the way for new therapeutic possibilities, including compounds capable of reducing neuroinflammation. Here, LRRK2 is linked to Parkinson disease.